is liraglutide a glp 1 Study shows results in increased insulin sensitivity independent of weight loss Liraglutide, a glucagon-like peptide-1 analog,

Two drugs are in Phase 1 trials: PegBios GCGR x GLP-1R dual agonist, PB-718, and United Bio-Technologys GCGR x GIPR x GLP-1R triple agonist,UBT-251

Diabetes Care 33(2):428433 Eguchi Y, Kitajima Y, Hyogo H, Takahashi H, Kojima M, Ono M et al (2015) Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J)

Doctors focus on ruling out conditions that mimic NAION, since some are more dangerous and require urgent treatment

These features are reminiscent of structural and functional changes in the brains of middle-aged and elderly individuals with long-standing T2DM, with otherwise normal cognition, who also exhibit variable cortical atrophy and regional decline in the glucose metabolism

However, whether orforglipron's partial agonist profile translates into clinical differences in durability of response compared to full agonists remains an open question that will require long-term comparative studies to address

Beyond these regions, relevant GLP-1 receptor populations have been identified in at least 10 additional brain areas, pointing to physiological roles that extend well beyond feeding